Shorooq’s Post

View organization page for Shorooq, graphic

43,522 followers

1mo

What does it take to become the Blackstone of the Middle East? In this fascinating interview with Imogen Lillywhite, Mahmoud Adi explains how we aim to bridge a critical gap for early-stage companies across the MENA region, giving them a strategic path from seed to IPO and beyond. 👉 Read the full story on ZAWYA: https://lnkd.in/gQWj7atv With Founders. For Investors. #Shorooq

6 Comments

Venture Chronicle

1mo

👀👀

1 Reaction

Bassel El Toukhy

Group Chief Operations Officer at valU | ex-P&G, Uber & Amazon

1mo

Onwards & upwards 🚀

Tewfik Cassis

CPO @ Lean Technologies

1mo

BIG BIG MOVES

1 Reaction

Shorooq

1mo

Mahmoud Adi Shane Shin (شين شن) 유근 Tamer Azer Kunal Savjani Bilal Baloch Tarek Fouad Yousef Albabtain Mohammed Altwaijri Sali Elagab Omer Zabit Tina Daher Maciej Dyl Maya Milan Selim Tira Tarek Bilani Mouzaffar Alwan Nathan Yonghyun Kwon Passant Abed Ahmed Elgabri Nada Khouri Lamis E.. Fahad Naqi Khan, CA Joe Barron, CFA Sana Currimbhoy Maha Dwekat Karen Gobran Shahir Henry

See more comments

To view or add a comment, sign in

More Relevant Posts

Mizuho Investment & Corporate Banking

25,519 followers
5mo
Report this post
Higher financing costs and even higher valuation expectations have stalled venture-backed and private equity portfolio companies seeking exits. Deal activity has been concentrated with larger, strategic M&A eclipsing sponsor activity and new issues have tended to be larger. In fact, the average size of an IPO has increased by 25% over the last 15 years to roughly $300 million Michal Katz told a group of investors during the panel discussion “Dealmaking for the Next Decade: Going Public, Taking Private, and Everything In Between” at the Forbes Iconoclast Summit in New York last month. #thisismizuho #forbesiconoclast #IPO Click here to watch the full panel: https://lnkd.in/eEpHhAD7
1 Comment
Like Comment
To view or add a comment, sign in
Mickaël Bouvet-Gueguen, PhD, MBA

Life Sciences Strategy, Global Strategy Group at KPMG Switzerland
1mo
Report this post
📣 Out now: European Life Sciences deals overview Q3 2024 🔎 We are keeping a close eye on the Life Sciences deal activity in Europe and have gathered all the details and insights from the last quarter. Our report discusses: ● the latest M&A, VC & growth capital, and IPO & follow-on deals ● key year-on-year developments from Q3 2023 to Q3 2024 ● key acquirers and notable investors in the Life Sciences industry 🚀 Ready to stay ahead? Read our full report here: https://lnkd.in/e85MV9X6
Like Comment
To view or add a comment, sign in
Jan-Patrick Willmes (FCIPS)

Sustainable Procurement Excellence - delivered!
1mo
Report this post
📣 Out now: European Life Sciences deals overview Q3 2024 🔎 We are keeping a close eye on the Life Sciences deal activity in Europe and have gathered all the details and insights from the last quarter. Our report discusses: ● the latest M&A, VC & growth capital, and IPO & follow-on deals ● key year-on-year developments from Q3 2023 to Q3 2024 ● key acquirers and notable investors in the Life Sciences industry 🚀 Ready to stay ahead? Read our full report here: https://lnkd.in/dAUNwg7M
Like Comment
To view or add a comment, sign in
René Koets
9mo
Report this post
Discover the latest trends and 2024 outlook for life sciences deals involving European targets. Our publication delivers an overview of the European deals landscape including M&A, Venture Capital and IPO deal trends. Explore our full publication. #LifeSciences #Europe #Deals #MergersandAcquisitions #VentureCapital #IPO

Overview and outlook of European Life Sciences deals 2023 & 2024

kpmgswitzerland.smh.re
Like Comment
To view or add a comment, sign in
Till Ferst

Head of Tax & Legal St. Gallen | Tax Director | Tax Services for Entrepreneurs & Executives | Start-Up's, SME + MNE | KPMG Switzerland
9mo
Report this post
Discover the latest trends and 2024 outlook for life sciences deals involving European targets. Our publication delivers an overview of the European deals landscape including M&A, Venture Capital and IPO deal trends. Explore our full publication. #LifeSciences #Europe #Deals #MergersandAcquisitions #VentureCapital #IPO

Overview and outlook of European Life Sciences deals 2023 & 2024

kpmgswitzerland.smh.re
Like Comment
To view or add a comment, sign in
Marc Gössi

Partner at KPMG, Global Lead Partner, Financial Services & Consumer and Retail
1mo
Report this post
📣 Out now: European Life Sciences deals overview Q3 2024 🔎 We are keeping a close eye on the Life Sciences deal activity in Europe and have gathered all the details and insights from the last quarter. Our report discusses: ● the latest M&A, VC & growth capital, and IPO & follow-on deals ● key year-on-year developments from Q3 2023 to Q3 2024 ● key acquirers and notable investors in the Life Sciences industry 🚀 Ready to stay ahead? Read our full report here: https://lnkd.in/eM4aGYX2
Like Comment
To view or add a comment, sign in
Desi Miteva

Corporate Sustainability
1mo
Report this post
📣 Out now: European Life Sciences deals overview Q3 2024 🔎 We are keeping a close eye on the Life Sciences deal activity in Europe and have gathered all the details and insights from the last quarter. Our report discusses: ● the latest M&A, VC & growth capital, and IPO & follow-on deals ● key year-on-year developments from Q3 2023 to Q3 2024 ● key acquirers and notable investors in the Life Sciences industry 🚀 Ready to stay ahead? Read our full report here: https://lnkd.in/dSznSBUg
Like Comment
To view or add a comment, sign in
EUVC

10,792 followers
2mo Edited
Report this post
Capital allocation by Sagar T., Partner at Beyond Impact VC and author of first followers. 👇 Why it matters.👇 CEOs can unlock substantial shareholder returns with strategies like buybacks, acquisitions, and R&D. Serial acquirers, like Teledyne, use disciplined acquisitions to mimic organic growth and drive resilience. Free cash flow is king, but strategic decisions around debt, equity, and divestments are necessary for sustainable growth. Understanding and mastering capital allocation is a game-changer for founders, turning them into savvy investors. Read the full article on EUVC Insights! 🔽 https://buff.ly/4eGOtzz #venturecapital #startupfunding #Europe #EUVCInsights
Like Comment
To view or add a comment, sign in
Matthias Bossardt
9mo
Report this post
Discover the latest trends and 2024 outlook for life sciences deals involving European targets. Our publication delivers an overview of the European deals landscape including M&A, Venture Capital and IPO deal trends. Explore our full publication. #LifeSciences #Europe #Deals #MergersandAcquisitions #VentureCapital #IPO

Overview and outlook of European Life Sciences deals 2023 & 2024

kpmgswitzerland.smh.re
Like Comment
To view or add a comment, sign in
Konstantin Petropoulos

Director Accounting & Payroll Services @ KPMG
9mo
Report this post
Discover the latest trends and 2024 outlook for life sciences deals involving European targets. Our publication delivers an overview of the European deals landscape including M&A, Venture Capital and IPO deal trends. Explore our full publication. #LifeSciences #Europe #Deals #MergersandAcquisitions #VentureCapital #IPO

Overview and outlook of European Life Sciences deals 2023 & 2024

kpmgswitzerland.smh.re
Like Comment
To view or add a comment, sign in

43,522 followers

View Profile Connect

Shorooq’s Post

More from this author

Strategies for Startups in a Rebounding Market

Revolutionizing Real Estate: PropTech Innovations Transforming Saudi Arabia

Top 5 Takeaways from Careem's AI Journey With Chief of Staff, AI and Innovation, Ceren Gokoglu

Explore topics